Clinical Trials Directory

Trials / Completed

CompletedNCT07439068

A-PRF and CGF in Palatal Donor Site Healing

Effects on Patients' Postoperative Morbidity and Donor Site Wound Healing of A-PRF and CGF Application After Free Gingival Graft Harvesting: A Comparative Randomized Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Ordu University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The objective of this study was to compare and evaluate the effects of concentrated growth factor (CGF) and advanced platelet-rich fibrin (A-PRF) clot membranes on palatal epithelial wound healing and postoperative discomfort following free gingival graft (FGG) harvesting.

Detailed description

The objective of this study was to compare and evaluate the effects of concentrated growth factor (CGF) and advanced platelet-rich fibrin (A-PRF) clot membranes on palatal epithelial wound healing and postoperative discomfort following free gingival graft (FGG) harvesting. Fourty-five patients who underwent FGG harvesting were randomly assigned to three groups: (1) control group (n=15), receiving only a sterile gelatin sponge; (2) A-PRF group (n=15), receiving A-PRF clot membranes; and (3) CGF group (n=15), receiving CGF clot membranes at the donor site. The epithelization rate, color match, and sensation scores of the palatal wound were assessed at 1, 2, 3, and 4 weeks postoperatively. Pain levels, analgesic consumption, and bleeding time were self-reported by patients for the first 7 days of healing.

Conditions

Interventions

TypeNameDescription
PROCEDUREAdvanced platelet-rich fibrinAdvanced platelet-rich fibrin membranes and free gingival graft
PROCEDUREConcentrated growth factorConcentrated growth factor membranes and free gingival graft
PROCEDURESterile gelatin spongeSterile gelatin sponge and free gingival graft

Timeline

Start date
2020-11-01
Primary completion
2022-05-30
Completion
2022-05-31
First posted
2026-02-27
Last updated
2026-02-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07439068. Inclusion in this directory is not an endorsement.